Cue Health to Participate at Upcoming Investor Conferences

Rhea-AI Summary

Cue Health (Nasdaq: HLTH), a pioneering healthcare technology company, announced its participation in two prominent investor conferences. The first is the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference on February 16, 2023, in Snowbird, UT. The second is the 43rd Annual Cowen Healthcare Conference on March 7, 2023, at 12:50 p.m. Eastern Time, in Boston, MA. Investors can access a live audio webcast of the Cowen presentation for 180 days via Cue Health's website. Founded in 2010 and based in San Diego, Cue Health aims to enhance healthcare access and diagnostics with innovative solutions.

SAN DIEGO--(BUSINESS WIRE)-- Cue Health (“Cue”) (Nasdaq: HLTH), the healthcare technology company known for diagnostic enabled care, announced today that its management team will participate at the following investor conferences:

• BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
  Participating on Thursday, February 16, 2023 at The Cliff Lodge in Snowbird, UT.

• 43^rd Annual Cowen Healthcare Conference
  Presenting on Tuesday, March 7, 2023 at 12:50 p.m. Eastern Time at the Boston Marriott Copley Place in Boston, MA. A live audio webcast and replay of the presentation may be accessed for 180 days on the “Investor Relations” section of the company’s website at: https://cuehealth.com/.

About Cue Health

Cue Health (Nasdaq: HLTH) is a healthcare technology company that makes it easier for individuals to access health information and places diagnostic information at the center of care. Cue Health enables people to manage their health through real-time, actionable, and connected health information, offering individuals and their healthcare providers easy access to lab-quality diagnostics anywhere, anytime, in a device that fits in the palm of the hand. Cue Health's first-of-its-kind COVID-19 test was the first FDA-authorized molecular diagnostic test for at-home and over-the-counter use without a prescription and physician supervision. Outside the United States, Cue Health has received the CE mark in the European Union, Interim Order authorization from Health Canada, regulatory approval from India's Central Drugs Standard Control Organization, and PSAR authorization from Singapore’s Health Sciences Authority. Cue was founded in 2010 and is headquartered in San Diego. For more information, please visit www.cuehealth.com. 

View source version on businesswire.com: https://www.businesswire.com/news/home/20230202005750/en/

Contact Us

Lorna Williams ir@cuehealth.com

858-667-4934 (ext. 1104)

Cue Health

press@cuehealth.com

Source: Cue Health Inc.

FAQ

What conferences will Cue Health participate in during February and March 2023?

Cue Health will participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference on February 16, 2023, and the 43rd Annual Cowen Healthcare Conference on March 7, 2023.

When is Cue Health presenting at the Cowen Healthcare Conference?

Cue Health will present at the Cowen Healthcare Conference on March 7, 2023, at 12:50 p.m. Eastern Time.

Where will the BTIG MedTech Conference be held?

The BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference will be held in Snowbird, UT.

How can I access Cue Health's Cowen Conference presentation?

You can access Cue Health's Cowen Conference presentation via a live audio webcast available on their website for 180 days.

What does Cue Health specialize in?

Cue Health specializes in healthcare technology, focusing on diagnostic-enabled care and providing easy access to lab-quality diagnostics.